Compare SEGG & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEGG | VTAK |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | 12 | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 4.1M |
| IPO Year | 2023 | 2018 |
| Metric | SEGG | VTAK |
|---|---|---|
| Price | $2.14 | $2.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 32.3K |
| Earning Date | N/A | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $730,000.00 |
| Revenue This Year | N/A | $822.86 |
| Revenue Next Year | N/A | $168.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 82.96 |
| 52 Week Low | N/A | $1.49 |
| 52 Week High | N/A | $15.68 |
| Indicator | SEGG | VTAK |
|---|---|---|
| Relative Strength Index (RSI) | 75.72 | 47.93 |
| Support Level | $0.46 | $1.98 |
| Resistance Level | $4.65 | $2.35 |
| Average True Range (ATR) | 0.48 | 0.13 |
| MACD | 0.20 | 0.03 |
| Stochastic Oscillator | 39.50 | 57.05 |
Lottery.com Inc is a provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.